Related Experiment Video
Updated: Sep 21, 2025

Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
Published on: May 16, 2022
Calcitonin gene-related peptide antagonist therapy and migraines
1Andrew Zolp is an assistant professor in the PA program at Western Michigan University and practices at Bronson Primary Care Partners, both in Kalamazoo, Mich. The author has disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Calcitonin gene-related peptide antagonists are a novel new class of medications that have been shown to reduce migraine headache pain and bothersome symptoms in patients who have had an insufficient response to triptans or for whom triptans are contraindicated. This article describes the new medications.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Antiepileptic Drugs: Glutamate Antagonists
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drugs Acting on Autonomic Ganglia: Blockers

